“Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s128. https://doi.org/10.25251/skin.7.supp.128.